Vertex Pharmaceuticals Total Non-Cash Items 2010-2025 | VRTX

Vertex Pharmaceuticals total non-cash items for the twelve months ending March 31, 2025 were $1.484B, a 296.47% increase year-over-year.

  • Vertex Pharmaceuticals annual total non-cash items for 2024 were $0.558B, a 204.14% increase from 2023.
  • Vertex Pharmaceuticals annual total non-cash items for 2023 were $0.183B, a 60.74% decline from 2022.
  • Vertex Pharmaceuticals annual total non-cash items for 2022 were $0.467B, a 14.88% increase from 2021.

Vertex Pharmaceuticals Total Non-Cash Items 2010-2025 | VRTX

  • Vertex Pharmaceuticals annual total non-cash items for 2024 were $0.558B, a 204.14% increase from 2023.
  • Vertex Pharmaceuticals annual total non-cash items for 2023 were $0.183B, a 60.74% decline from 2022.
  • Vertex Pharmaceuticals annual total non-cash items for 2022 were $0.467B, a 14.88% increase from 2021.